These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27544683)

  • 1. Prediction of Poor Response to Modified Neuroleptanalgesia with Midazolam for Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma.
    Ominami M; Nagami Y; Shiba M; Tominaga K; Maruyama H; Okamoto J; Kato K; Minamino H; Fukunaga S; Sugimori S; Yamagami H; Tanigawa T; Watanabe T; Fujiwara Y; Arakawa T
    Digestion; 2016; 94(2):73-81. PubMed ID: 27544683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of propofol with midazolam in endoscopic submucosal dissection for esophageal squamous cell carcinoma: a randomized controlled trial.
    Ominami M; Nagami Y; Shiba M; Tominaga K; Sakai T; Maruyama H; Kato K; Minamino H; Fukunaga S; Tanaka F; Sugimori S; Kamata N; Machida H; Yamagami H; Tanigawa T; Watanabe T; Fujiwara Y; Arakawa T
    J Gastroenterol; 2018 Mar; 53(3):397-406. PubMed ID: 28600597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of novel sedation using the combination of dexmedetomidine and midazolam during endoscopic submucosal dissection for esophageal squamous cell carcinoma.
    Yoshio T; Ishiyama A; Tsuchida T; Yoshimizu S; Horiuchi Y; Omae M; Hirasawa T; Yamamoto Y; Sano H; Yokota M; Fujisaki J
    Esophagus; 2019 Jul; 16(3):285-291. PubMed ID: 30937573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of endoscopic submucosal tunnel dissection for superficial esophageal squamous cell carcinoma: a propensity score matching analysis.
    Huang R; Cai H; Zhao X; Lu X; Liu M; Lv W; Liu Z; Wu K; Han Y
    Gastrointest Endosc; 2017 Nov; 86(5):831-838. PubMed ID: 28286094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic submucosal dissection under general anesthesia for superficial esophageal squamous cell carcinoma is associated with better clinical outcomes.
    Song BG; Min YW; Cha RR; Lee H; Min BH; Lee JH; Rhee PL; Kim JJ
    BMC Gastroenterol; 2018 Jun; 18(1):80. PubMed ID: 29879909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midazolam and pethidine versus propofol and fentanyl patient controlled sedation/analgesia for upper gastrointestinal tract ultrasound endoscopy: a prospective randomized controlled trial.
    Agostoni M; Fanti L; Arcidiacono PG; Gemma M; Strini G; Torri G; Testoni PA
    Dig Liver Dis; 2007 Nov; 39(11):1024-9. PubMed ID: 17913605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of carbon dioxide insufflation in esophageal endoscopic submucosal dissection.
    Uemura M; Ishii N; Itoh T; Suzuki K; Fujita Y
    Hepatogastroenterology; 2012 May; 59(115):734-7. PubMed ID: 22020910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for intraoperative perforation during endoscopic submucosal dissection of superficial esophageal squamous cell carcinoma.
    Noguchi M; Yano T; Kato T; Kadota T; Imajoh M; Morimoto H; Osera S; Yagishita A; Odagaki T; Yoda Y; Oono Y; Ikematsu H; Kaneko K
    World J Gastroenterol; 2017 Jan; 23(3):478-485. PubMed ID: 28210084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pethidine hydrochloride is a better sedation method for pharyngeal observation by transoral endoscopy compared with no sedation and midazolam.
    Yamasaki Y; Ishihara R; Hanaoka N; Matsuura N; Kanesaka T; Akasaka T; Kato M; Hamada K; Tonai Y; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Ito Y; Yano M; Iishi H
    Dig Endosc; 2017 Jan; 29(1):39-48. PubMed ID: 27696551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic sedation with midazolam and propofol versus midazolam and pethidine in colonoscopies: a prospective, randomized study.
    Paspatis GA; Manolaraki M; Xirouchakis G; Papanikolaou N; Chlouverakis G; Gritzali A
    Am J Gastroenterol; 2002 Aug; 97(8):1963-7. PubMed ID: 12190161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reasonable decision of anesthesia methods in patients who underwent endoscopic submucosal dissection for superficial esophageal carcinoma: A retrospective analysis in a single Japanese institution.
    Yagi Kuwata N; Gotoda T; Suzuki S; Mukai S; Itoi T; Moriyasu F
    Turk J Gastroenterol; 2016 Mar; 27(2):91-6. PubMed ID: 27015614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-controlled sedation for colonoscopy: a randomized trial comparing patient-controlled administration of propofol and alfentanil with physician-administered midazolam and pethidine.
    Bright E; Roseveare C; Dalgleish D; Kimble J; Elliott J; Shepherd H
    Endoscopy; 2003 Aug; 35(8):683-7. PubMed ID: 12929065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of prednisone for prevention of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Zhou G; Yuan F; Cai J; Tang X; Gong W; Su L; Zhang Y
    Thorac Cancer; 2017 Sep; 8(5):489-494. PubMed ID: 28759148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The five-year survival rate after endoscopic submucosal dissection for superficial esophageal squamous cell neoplasia.
    Nagami Y; Ominami M; Shiba M; Minamino H; Fukunaga S; Kameda N; Sugimori S; Machida H; Tanigawa T; Yamagami H; Watanabe T; Tominaga K; Fujiwara Y; Arakawa T
    Dig Liver Dis; 2017 Apr; 49(4):427-433. PubMed ID: 28096057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of endoscopic submucosal dissection in elderly patients with esophageal squamous cell carcinoma.
    Song BG; Min YW; Lee JH; Lee H; Min BH; Rhee PL; Kim JJ
    Surg Endosc; 2017 Oct; 31(10):3905-3911. PubMed ID: 28342128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of metachronous recurrence after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
    Uno K; Koike T; Kusaka G; Takahashi Y; Ara N; Shimosegawa T
    Dis Esophagus; 2017 Jun; 30(6):1-8. PubMed ID: 28475742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for esophageal stenosis after entire circumferential endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    Miwata T; Oka S; Tanaka S; Kagemoto K; Sanomura Y; Urabe Y; Hiyama T; Chayama K
    Surg Endosc; 2016 Sep; 30(9):4049-56. PubMed ID: 26703127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control.
    Hisano O; Nonoshita T; Hirata H; Sasaki T; Watanabe H; Wakiyama H; Ono M; Ohga S; Honda H
    Radiat Oncol; 2018 Jan; 13(1):14. PubMed ID: 29378603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of endoscopic submucosal dissection for superficial esophageal neoplasms (KDOG 0901).
    Higuchi K; Tanabe S; Azuma M; Katada C; Sasaki T; Ishido K; Naruke A; Katada N; Koizumi W
    Gastrointest Endosc; 2013 Nov; 78(5):704-10. PubMed ID: 23680178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic submucosal dissection for superficial esophageal cancer.
    Aadam AA; Abe S
    Dis Esophagus; 2018 Jul; 31(7):. PubMed ID: 29982386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.